Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
What if we could spot drug side effects before they reach patients? In this interview, Tom Lanz (Senior Director, Multi-Omics […]
Selecting the right AI strategy is critical to delivering accurate, timely, and impactful insights across drug discovery. With rapidly advancing technologies in foundation […]
Mark your calendar for Thursday 9th, 16th and 23rd October 2025 at 3pm BST | 4pm CEST | 10am ET. Epigenetic patterns […]
Mark your calendar for Tuesday 7th, 14th and 21st October 2025 at 3pm BST | 4pm CEST | 10am ET. […]
AI holds immense promise in accelerating drug discovery and development—but the journey from data to therapeutic impact is far from […]
Mark your calendar for Wednesday 23rd & 30th April at 3pm BST | 4pm CEST | 10am ET. Discover how […]
The Festival of Genomics and Biodata is just around the corner, and we’ve had the opportunity to sit down with […]
Back in 2020, we covered an industry analysis of the role of Artificial Intelligence in Drug Discovery. The report covered […]
On average, it takes 10.5 years for a Phase I drug to progress to regulatory approval and only ~8% of […]
